Medical Assessment and Triage of Pediatric Patients with Anorexia Nervosa in Primary Care

Kendra J Homan1, Leslie A Sim1, Susan L Crowley2

  • 1Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, MN. Dr. Homan is now with the Cincinnati Children's Hospital Medical Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Insights

Pediatric patients with anorexia nervosa (AN) often miss diagnoses and appropriate care in primary settings. Early, evidence-based triage in primary care significantly improves diagnosis and treatment timelines for AN.

Area of Science:

  • Pediatric Medicine
  • Eating Disorders
  • Primary Care

Background:

  • Anorexia nervosa (AN) is a serious eating disorder affecting pediatric populations.
  • Early identification and intervention are crucial for favorable outcomes in pediatric AN.
  • Primary care settings are often the first point of contact for children with potential eating disorders.

Purpose of the Study:

  • To evaluate the medical assessment and triage of pediatric patients diagnosed with anorexia nervosa (AN) in primary care.
  • To identify deviations from recommended practice guidelines in the initial management of pediatric AN in primary care.
  • To explore the impact of appropriate triage on the timeliness of diagnosis and treatment.

Main Methods:

  • Retrospective cohort study of pediatric patients with AN symptoms identified in primary care.
  • Data abstracted from medical records between 2010 and 2016.
  • Analysis of presenting concerns, medical assessments, laboratory tests, diagnoses, and treatment recommendations.

Main Results:

  • Only 5% of pediatric AN patients received a diagnosis during their initial primary care visit.
  • A minority of patients were assessed for critical complications like electrolyte disturbances or hypothermia.
  • 56% received triage consistent with recommendations, but only 2 patients meeting inpatient criteria were hospitalized.
  • Appropriate triage correlated with significantly earlier AN diagnosis and treatment.

Conclusions:

  • Pediatric patients with AN may not receive adequate medical assessment and triage in primary care settings.
  • Barriers to evidence-based care for pediatric eating disorders need to be understood.
  • Improved provider education and system changes are necessary to enhance outcomes for pediatric AN patients.
Abstract

Related Concept Videos

Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
1.2K
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
301
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
291